Page Bouchard

1.5k total citations
22 papers, 1.1k citations indexed

About

Page Bouchard is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Page Bouchard has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Page Bouchard's work include Immune Cell Function and Interaction (7 papers), Inflammasome and immune disorders (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Page Bouchard is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Inflammasome and immune disorders (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Page Bouchard collaborates with scholars based in United States, Switzerland and France. Page Bouchard's co-authors include Kristin Thompson, Renta Hutabarat, William E. Carson, W. James Metzger, Sanjiv Sur, D. Holbert, Jonathan Lam, Julie Dierksheide, Michael A. Caligiuri and Carol Becker Lynch and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Page Bouchard

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Page Bouchard United States 14 511 438 283 107 100 22 1.1k
Yong Ke United States 17 545 1.1× 415 0.9× 204 0.7× 49 0.5× 68 0.7× 30 1.3k
Janet Weinstock Australia 20 265 0.5× 514 1.2× 334 1.2× 89 0.8× 162 1.6× 35 1.3k
Sherry L. LaPorte United States 9 510 1.0× 363 0.8× 268 0.9× 131 1.2× 146 1.5× 11 1.2k
Norihiko Narita Japan 20 462 0.9× 398 0.9× 379 1.3× 205 1.9× 58 0.6× 92 1.4k
Margery A. Chaikin United States 19 654 1.3× 610 1.4× 386 1.4× 101 0.9× 241 2.4× 27 1.8k
Christel Goudot France 13 975 1.9× 558 1.3× 425 1.5× 51 0.5× 38 0.4× 21 1.5k
B. Angermann United States 14 687 1.3× 364 0.8× 144 0.5× 96 0.9× 30 0.3× 25 1.2k
Jennifer Ferguson United Kingdom 21 185 0.4× 565 1.3× 349 1.2× 43 0.4× 105 1.1× 37 1.4k
Mary S. Rosendahl United States 18 209 0.4× 604 1.4× 227 0.8× 46 0.4× 118 1.2× 27 1.2k
Randall S. Gieni Canada 14 347 0.7× 357 0.8× 117 0.4× 156 1.5× 37 0.4× 18 1.0k

Countries citing papers authored by Page Bouchard

Since Specialization
Citations

This map shows the geographic impact of Page Bouchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Page Bouchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Page Bouchard more than expected).

Fields of papers citing papers by Page Bouchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Page Bouchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Page Bouchard. The network helps show where Page Bouchard may publish in the future.

Co-authorship network of co-authors of Page Bouchard

This figure shows the co-authorship network connecting the top 25 collaborators of Page Bouchard. A scholar is included among the top collaborators of Page Bouchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Page Bouchard. Page Bouchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouchard, Page, et al.. (2025). Toxicologic Pathology. 1 indexed citations
2.
Pognan, François, Maria Papoutsi, David Ledieu, et al.. (2018). Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human. Archives of Toxicology. 92(5). 1877–1891. 3 indexed citations
3.
Uteng, Marianne, László Urbán, Dominique Brees, et al.. (2018). Safety differentiation: emerging competitive edge in drug development. Drug Discovery Today. 24(1). 285–292. 1 indexed citations
4.
Walles, Markus, et al.. (2018). Hepatotoxicity with antibody maytansinoid conjugates: A review of preclinical and clinical findings. Journal of Applied Toxicology. 38(5). 600–615. 21 indexed citations
5.
Moggs, Jonathan G., Pierre Moulin, François Pognan, et al.. (2012). Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology. 8(9). 1071–1082. 13 indexed citations
6.
Lesinski, Gregory B., Kristan Guenterberg, Michael R. Go, et al.. (2008). IFN-α and Bortezomib Overcome Bcl-2 and Mcl-1 Overexpression in Melanoma Cells by Stimulating the Extrinsic Pathway of Apoptosis. Cancer Research. 68(20). 8351–8360. 44 indexed citations
7.
Sasseville, Vito G., Joan H. Lane, Vivek J. Kadambi, et al.. (2004). Testing paradigm for prediction of development-limiting barriers and human drug toxicity. Chemico-Biological Interactions. 150(1). 9–25. 13 indexed citations
8.
Leplège, Alain, Emmanuel Écosse, S Arlot, et al.. (2003). [Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency].. PubMed. 64(3). 191–7. 3 indexed citations
9.
10.
Albert, Leo, et al.. (2002). Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. The Pharmacogenomics Journal. 2(6). 383–399. 11 indexed citations
11.
Trepicchio, William L., et al.. (2001). Protective Effect of rhIL-11 in a Murine Model of Acetaminophen-Induced Hepatotoxicity. Toxicologic Pathology. 29(2). 242–249. 34 indexed citations
12.
Albert, Leo, et al.. (2000). In Vivo Absorption Properties of Orally Administered Recombinant Human Interleukin-11. Pharmaceutical Research. 17(4). 482–485. 5 indexed citations
13.
14.
Erickson, Jamie, et al.. (1999). Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology. 30(6). 1441–1447. 60 indexed citations
15.
Carson, William E., Haixin Yu, Julie Dierksheide, et al.. (1999). A Fatal Cytokine-Induced Systemic Inflammatory Response Reveals a Critical Role for NK Cells. The Journal of Immunology. 162(8). 4943–4951. 91 indexed citations
16.
Boggio, K, Giordano Nicoletti, Emma Di Carlo, et al.. (1998). Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice. The Journal of Experimental Medicine. 188(3). 589–596. 255 indexed citations
17.
Schaub, Robert G., et al.. (1998). Preclinical studies of recombinant factor IX.. PubMed. 35(2 Suppl 2). 28–32. 5 indexed citations
18.
Bouchard, Page, et al.. (1996). Carcinogenicity of CoCrMo (F-75) implants in the rat. Journal of Biomedical Materials Research. 32(1). 37–44. 13 indexed citations
19.
Sur, Sanjiv, et al.. (1996). Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. The Journal of Immunology. 157(9). 4173–4180. 122 indexed citations
20.
Bouchard, Page & Carol Becker Lynch. (1989). Burrowing behavior in wild house mice: Variation within and between populations. Behavior Genetics. 19(3). 447–456. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Ke Breakdown of academic impact, for papers by Janet Weinstock Breakdown of academic impact, for papers by Sherry L. LaPorte Breakdown of academic impact, for papers by Norihiko Narita Breakdown of academic impact, for papers by Margery A. Chaikin Breakdown of academic impact, for papers by Christel Goudot Breakdown of academic impact, for papers by B. Angermann Breakdown of academic impact, for papers by Jennifer Ferguson Breakdown of academic impact, for papers by Mary S. Rosendahl Breakdown of academic impact, for papers by Randall S. Gieni
Rankless by CCL
2026